XML 58 R45.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions And Other Transactions (Pro Forma Financial Information) (Details) (Bioniche Pharma Holdings Limited, USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2010
Bioniche Pharma Holdings Limited
 
Business Acquisition, Pro Forma Information [Abstract]  
Total revenues $ 5,561,801
Net earnings attributable to Mylan Inc. before preferred dividends 355,626
Preferred dividends 121,535
Net earnings attributable to Mylan Inc. common shareholders $ 234,091
Earnings per common share attributable to Mylan Inc. common shareholders:  
Basic $ 0.72
Diluted $ 0.71
Weighted average common shares outstanding:  
Basic 324,453
Diluted 328,979